Lev Facher covers the U.S. addiction and overdose crisis. Patients who received higher doses of buprenorphine, a common medication used to alleviate opioid withdrawal and cravings, were less likely to ...

EYEWITNESS NEWS (WBRE/WYOU) — The U.S. Food and Drug Administration (FDA) approved a Buprenorphine treatment option for opioid addiction. According to the FDA, Brixadi is an extended-release injection ...

Buprenorphine, an important drug in fighting the opioid crisis, has long been closely monitored over concerns it would be abused. But a first-of-its-kind government oversight report released Thursday ...

Adolescents who seek treatment for opioid addiction at an inpatient facility are more likely to be offered horseback riding than given full access to a common, highly effective addiction medication.

Twenty-four percent of US adolescent treatment centers do not use a “lifesaving” medication. An article appeared today in the Journal of the American Medical Association titled “Treatments Used Among ...

While my wife and 2-year old daughter watched TV in the living room, I was in the kitchen, measuring the distance from the tip of my index finger to my armpit. I needed to know I could pull the ...

Close up of fingers picking up a small pink Suboxone pill. The opioid epidemic is a public health emergency that claims the lives of more than 100 people in the United States every day on average, ...

As the COVID-19 pandemic unfolded in 2020, the Drug Enforcement Administration (DEA) ushered in groundbreaking telemedicine flexibilities pursuant to its public health emergency (PHE) authority under ...

Please provide your email address to receive an email when new articles are posted on . Approximately 22% of addiction treatment facilities require adolescents be off buprenorphine prior to admission.

Suboxone is now the standard of care in the U.S. for treating opioid addiction, but its downsides are often overlooked. RFK ...

Stacey McKenna, Resident Senior Fellow, Healthier Communities, R Street Institute In SUPPORT of Senate Bill 562, “State Board of Pharmacy – Prescriber-Pharmacist Agreements – Treatment of Opioid Use ...